1. Discovery of cell-active phenyl-imidazole Pin1 inhibitors by structure-guided fragment evolution.
- Author
-
Potter A, Oldfield V, Nunns C, Fromont C, Ray S, Northfield CJ, Bryant CJ, Scrace SF, Robinson D, Matossova N, Baker L, Dokurno P, Surgenor AE, Davis B, Richardson CM, Murray JB, and Moore JD
- Subjects
- Caco-2 Cells, Drug Discovery, Humans, Imidazoles chemistry, Models, Molecular, Molecular Structure, NIMA-Interacting Peptidylprolyl Isomerase, Imidazoles pharmacology, Peptidylprolyl Isomerase antagonists & inhibitors
- Abstract
Pin1 is an emerging oncology target strongly implicated in Ras and ErbB2-mediated tumourigenesis. Pin1 isomerizes bonds linking phospho-serine/threonine moieties to proline enabling it to play a key role in proline-directed kinase signalling. Here we report a novel series of Pin1 inhibitors based on a phenyl imidazole acid core that contains sub-μM inhibitors. Compounds have been identified that block prostate cancer cell growth under conditions where Pin1 is essential., (Copyright © 2010 Elsevier Ltd. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF